Company Revenue

The company grew almost 33% in 2021 and expects its focus on medical education and enabling technology will spur further...

The company grew in the low-teens for 2021 but the ongoing effects of the pandemic caused Anika to adjust its...

The company grew +25% in 2022 and took its U.S. business to the next level with the acquisition of Nextremity...

The company grew nearly 65% in 2021 and believes its focus on bunion surgery will reveal further opportunities for clinical...

The company grew nearly 38% in 2021 and expects another strong year in 2022 on the strength of a growing...

The company grew 45% in 2021 on the strength of non-recurring royalty payments, but product revenue remains well below pre-pandemic...

The company grew nearly 70% in 2021, making it one of the premier growth stories in medtech. ATEC is bullish...

The company grew over 20% in 2021 and expects similar growth in 2022 due to its expanded portfolio and exclusive...

The company grew almost 19% in 2021 while playing plans to expand production capacity and expand MACI's indication to the...

The company grew 1% over its 2019 total and sees this year as a bridge to consistent mid-single-digit growth in...